SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-279380
Filing Date
2023-11-17
Accepted
2023-11-17 09:09:31
Documents
20
Period of Report
2023-11-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d614732d8k.htm   iXBRL 8-K 43830
2 EX-4.1 d614732dex41.htm EX-4.1 89400
3 EX-4.2 d614732dex42.htm EX-4.2 88048
4 EX-5.1 d614732dex51.htm EX-5.1 8959
5 EX-10.1 d614732dex101.htm EX-10.1 204130
6 EX-10.2 d614732dex102.htm EX-10.2 19760
7 EX-99.1 d614732dex991.htm EX-99.1 10661
11 GRAPHIC g614732g1116112155114.jpg GRAPHIC 2030
12 GRAPHIC g614732g1116210915528.jpg GRAPHIC 4377
  Complete submission text file 0001193125-23-279380.txt   729018

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA maia-20231115.xsd EX-101.SCH 2851
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE maia-20231115_lab.xml EX-101.LAB 18738
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE maia-20231115_pre.xml EX-101.PRE 11708
14 EXTRACTED XBRL INSTANCE DOCUMENT d614732d8k_htm.xml XML 3445
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 231416724
SIC: 2834 Pharmaceutical Preparations